A detailed history of Farringdon Capital, Ltd. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 4,324 shares of ZBH stock, worth $388,770. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,324
Previous 6,259 30.92%
Holding current value
$388,770
Previous $571 Million 25.39%
% of portfolio
0.11%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$90.62 - $107.71 $175,349 - $208,418
-1,935 Reduced 30.92%
4,324 $426 Million
Q2 2025

Aug 14, 2025

BUY
$90.21 - $112.66 $564,624 - $705,138
6,259 New
6,259 $571 Million
Q4 2024

Feb 13, 2025

BUY
$101.77 - $113.02 $497,757 - $552,780
4,891 New
4,891 $517 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $18.9B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Farringdon Capital, Ltd. Portfolio

Follow Farringdon Capital, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farringdon Capital, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Farringdon Capital, Ltd. with notifications on news.